Skip to content

Clinical trials

Carcinoma, Bronchogenic trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Status: Unknown status Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20142
20151
20163
20171
20182
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation1
Capital Medical University1
Centre Hospitalier Universitaire Dijon1
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.1
Jiangsu HengRui Medicine Co., Ltd.1
RWTH Aachen University1
Revolution Medicines, Inc.1
Shanghai Gebaide Biotechnology Co., Ltd.1
Shanghai Yunying Medical Technology1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic14
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Bronchial Neoplasms6
Lung Diseases6
Head and Neck Neoplasms5
Neoplasms5
Respiratory Tract Diseases4
Thoracic Neoplasms4
Respiratory Tract Neoplasms3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.